DIAGNOSTIC CYTOGENETICS
NPI 1104899376
Clinical Medical Laboratory in Seattle, WA

NPI Status: Active since February 08, 2006

Contact Information

2360 W COMMODORE WAY STE 201
SEATTLE, WA
ZIP 98199
Phone: (206) 328-2026
Fax: (206) 325-2975

Get Directions Write a Review

  • Organization
  • Clinical Medical Laboratory
  • Accepts Insurance
  • CLIA Number: 50D0721329
  • CLIA Cert. Type: Independent
  • CLIA Exp. Date: 04-04-2028

About DIAGNOSTIC CYTOGENETICS

This page provides the complete NPI Profile along with additional information for Diagnostic Cytogenetics, a provider established in Seattle, Washington operating as a Clinical Medical Laboratory. The healthcare provider is registered in the NPI registry with number 1104899376 assigned on February 2006. The practitioner's primary taxonomy code is 291U00000X with license number MTS-0439 (WA). The provider is registered as an organization and their NPI record was last updated 3 years ago. The authorized official of this NPI record is Kyndra M Mcdougal (Chief Regulatory Officer)

NPI
1104899376
Provider Name
DIAGNOSTIC CYTOGENETICS
Entity Type
Organization
Location Address
2360 W COMMODORE WAY STE 201 SEATTLE, WA 98199
Location Phone
(206) 328-2026
Location Fax
(206) 325-2975
Mailing Address
2360 W COMMODORE WAY STE 201 SEATTLE, WA 98199
Mailing Phone
(206) 328-2026
Mailing Fax
(206) 325-2975
Is Sole Proprietor?
No
Is Organization Subpart?
No
Enumeration Date
02-08-2006
Last Update Date
02-16-2023
Code Navigator

Establishments like Diagnostic Cytogenetics are healthcare facilities that may perform a wide range of laboratory procedures, assisted by doctors and medical technologists. Laboratories can be categorized according to their function as common diagnostic labs or specialty labs that conduct specialized or confirmatory tests. Different clinical laboratories could specialize in clinical chemistry, clinical microbiology, hematology, serology, clinical microscopy, cytopathology, molecular biology, or public health. Please inquire directly with this provider to confirm their test menu.

Clinical labs in the U.S. that perform human testing are regulated by the Centers for Medicare & Medicaid Services (CMS) through the Clinical Laboratory Improvement Amendments (CLIA) program. The purpose of the CLIA program is to guarantee the quality of laboratory testing. This provider has a CLIA number assigned, and undergoes regular inspections to ensure compliance and quality.

Location Map

Specialty - Primary Taxonomy

The NPI enumerator requires providers to submit at least one taxonomy code. A taxonomy code is a unique 10-character code that describes the healthcare provider type, classification, and the area of specialization. There could be only one primary taxonomy code per NPI record. For individual NPIs the license data is associated to the taxonomy code.

Classification

Clinical Medical Laboratory

Taxonomy Code
291U00000X
Type
Laboratories
License No.
MTS-0439
License State
WA
Taxonomy Description
(1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology.

Insurance Plans Accepted

According to publicly available information the provider might be accepting the following health plans from these health insurance companies:

  • Core Bronze HSA 10600 - EPO
  • Core Bronze HSA 7500 - EPO
  • Core Bronze HSA 8300 - EPO
  • Core Gold 1500 - EPO
  • Core Gold 3000 - EPO
  • Core Silver 3500 - EPO
  • Core Silver 4500 - EPO
  • Core Silver 5000 - EPO
  • Core Silver 7500 - EPO
  • Core Standard Expanded Bronze HSA - EPO
  • Core Standard Gold - EPO
  • Core Standard Silver - EPO
  • PacificSource Oregon Standard Bronze HSA Plan Core - EPO
  • PacificSource Oregon Standard Gold Plan Core - EPO
  • PacificSource Oregon Standard Silver Plan Core - EPO
  • Premera Blue Cross Alaska One Gold - PPO
  • Premera Blue Cross Preferred Bronze 5800 HSA - PPO
  • Premera Blue Cross Preferred Bronze 6350 - PPO
  • Premera Blue Cross Preferred Gold 1500 - PPO
  • Premera Blue Cross Preferred Silver 4500 - PPO
  • Premera Blue Cross Standard Bronze II - PPO
  • Premera Blue Cross Standard Gold - PPO
  • Premera Blue Cross Standard Silver - PPO
  • Premera Blue Cross Family Dental - PPO
  • Premera Blue Cross Pediatric Dental - PPO

Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.

Specific plan information not avaialable, please contact the provider to verify if your insurance plan is accepted.

*Please verify directly with this provider to make sure your insurance plan is currently accepted.

Authorized Official

The authorized official is the designated individual with the legal authority to make changes to the provider’s official NPI record. For organizations, the authorized official must be a general partner, chairman of the board, CEO, CFO or a direct owner holding at least a 5 percent stake in the medical organization.

Authorized Official Name

KYNDRA M MCDOUGAL

Authorized Official Title
CHIEF REGULATORY OFFICER
Authorized Official Phone
(888) 618-9107

Additional Identifiers

The NPI Enumerator encourages providers to submit additional identifiers with their NPI application although the submission of this information is optional. The additional identifier(s) section includes other numbers or codes currently or formerly used as an identifier for the provider by other public healthcare entities. The identifiers may include UPIN, NSC, OSCAR, DEA, Medicaid State or PIN identification numbers.

Identifier Type / Code Identifier State Identifier Issuer
7271406MEDICAID (05)WA 

Areas of Expertise

The following services and procedures, recently provided to Medicare patients, illustrate the range of care this provider offers. This list reflects the variety of services available to all patients visiting the practice and is based on 2022 Medicare dataset. In general, the more frequently a provider treats specific conditions or performs particular procedures, the more experienced they become in addressing similar patient needs. The provider has delivered many of the services listed below to Medicare patients. Please note that this list does not include services provided to patients who are not covered by Medicare.

Analysis of urine, except immunoassays

Analysis of urine, often termed a urinalysis, is a routine test that checks for different substances present in the urine. It's a simple, non-invasive procedure that can help diagnose and monitor various health conditions, including kidney disease and diabetes.

This service was performed 63 times for 59 patients

Cell examination of specimen, selective cellular enhancement technique

Cell examination of a specimen using selective cellular enhancement technique is a lab process that improves the visibility of certain cells in a sample. It helps in identifying abnormalities or diseases. The process is non-invasive, safe, and aids in accurate diagnosis.

This service was performed 37 times for 36 patients

Chromosome analysis for genetic defects, additional cells counted, each study

Chromosome analysis is a study that examines your body's chromosomes to identify any genetic defects. In some cases, additional cells may be counted to ensure accuracy. This can provide valuable information about potential health risks and inform treatment decisions.

This service was performed 14 times for 13 patients

Chromosome analysis for genetic defects, additional karyotypes, each study

Chromosome analysis is a test that examines the number and structure of a person's chromosomes. This is done to identify any genetic defects. Additional karyotypes, each study, are further tests that look at the arrangement of these chromosomes. This can help in detecting genetic disorders.

This service was performed 104 times for 97 patients

Chromosome analysis for genetic defects, analyze 20-25 cells

Chromosome analysis is a test that evaluates your cells to check for genetic defects. In this procedure, 20-25 cells are examined under a microscope to identify any abnormalities. This information can help in diagnosing certain genetic conditions and guide treatment plans.

This service was performed 83 times for 80 patients

Chromosome analysis for genetic defects, count 5 cells

Chromosome analysis is a test that examines the number and structure of your cells. It helps identify any genetic defects that might cause health issues. In this procedure, 5 cells are analyzed to ensure accuracy. The results may provide crucial information for your health management.

This service was performed 20 times for 19 patients

Detection of mycoplasma genitalium by dna or rna probe

This procedure involves the use of special probes to identify the presence of a specific bacteria, Mycoplasma Genitalium, in your body. These probes detect the bacteria's unique DNA or RNA, helping to confirm if you have an infection.

This service was performed 141 times for 123 patients

Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique

A detection test by nucleic acid for chlamydia trachomatis, amplified probe technique, is a test that identifies the presence of a specific bacteria in the body. This bacteria can cause various health issues. The technique amplifies the sample to improve accuracy.

This service was performed 68 times for 52 patients

Detection test by nucleic acid for cytomegalovirus (cmv), amplified probe technique

A detection test by nucleic acid for cytomegalovirus (CMV) using an amplified probe technique is a lab procedure. It identifies the presence of CMV, a common virus, in your body. This technique amplifies the virus's genetic material, making it easier to detect.

This service was performed 109 times for 95 patients

Detection test by nucleic acid for herpes simplex virus, amplified probe technique

This test uses an amplified probe technique to identify the presence of the herpes simplex virus in your body. It works by detecting the virus's genetic material, or nucleic acid. The test is accurate, reliable, and can help in early detection and treatment.

This service was performed 110 times for 58 patients

Detection test by nucleic acid for human papillomavirus (hpv), high-risk types

This test detects high-risk types of HPV, a common virus. It's done by analyzing a small sample of cells for the presence of HPV DNA. The aim is to identify any high-risk types early, as they may increase the risk of certain health issues.

This service was performed 16 times for 15 patients

Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique

This is a lab test that checks for the presence of a specific bacteria called Neisseria gonorrhoeae in your body. It uses a technique called amplified probe, which makes many copies of the bacteria's genetic material (nucleic acid) to help detect it more easily.

This service was performed 70 times for 52 patients

Detection test by nucleic acid for organism, amplified probe technique

A nucleic acid detection test is a procedure to identify specific organisms in your body. This test uses an amplified probe technique, which magnifies the genetic material of the organism, making it easier to detect. It's a precise way to diagnose infections.

This service was performed 573 times for 89 patients

Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique

A detection test for Staphylococcus aureus uses a method called the amplified probe technique. This method identifies the bacteria's unique genetic material, or nucleic acid, helping to confirm its presence. It's a highly accurate way to detect this type of bacteria.

This service was performed 122 times for 110 patients

Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique

A detection test by nucleic acid for MRSA bacteria uses an amplified probe technique. It's a lab procedure that identifies the presence of MRSA, a type of bacteria resistant to many antibiotics. This test helps in deciding the best treatment.

This service was performed 27 times for 27 patients

Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique

A detection test by nucleic acid for Group B Strep uses an amplified probe technique. This test identifies the presence of Group B Strep bacteria in the body. It involves collecting a sample, usually a swab, which is then examined in a lab for the bacteria's genetic material.

This service was performed 139 times for 124 patients

Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique

This is a test to identify a common microscopic organism that can cause discomfort. The technique involves using a special probe to amplify the organism's genetic material, making it easier to detect. It's a simple, safe, and accurate procedure.

This service was performed 62 times for 54 patients

Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique

The detection test by nucleic acid for vancomycin-resistant strep (VRE) is a laboratory procedure. It uses an amplified probe technique to identify specific genetic material in bacteria. This helps determine if the bacteria are resistant to the antibiotic vancomycin.

This service was performed 20 times for 20 patients

Detection test for candida species (yeast), amplified probe technique

This test helps identify Candida, a type of fungus often present in the human body. An amplified probe technique is used, which enhances detection of the fungus in a sample. This method increases the accuracy of the test, helping to determine the best treatment.

This service was performed 163 times for 29 patients

Detection test for gardnerella vaginalis (bacteria), amplified probe technique

This test helps find a specific type of bacteria in the body. It uses a method called the amplified probe technique, which amplifies the bacteria's genetic material, making it easier to detect. It's a standard, pain-free procedure.

This service was performed 68 times for 55 patients

Identification of organisms by genetic analysis, amplified probe technique

This procedure involves identifying organisms like bacteria or viruses in your body. It's done by amplifying a small part of their genetic material, making it easier to detect. This technique helps in accurate diagnosis and appropriate treatment.

This service was performed 309 times for 32 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within

This is a test to detect the COVID-19 virus. It uses a technique that amplifies the virus's genetic material (DNA or RNA) for detection. High throughput technologies are used for rapid and large-scale testing. The procedure is completed within a set time frame.

This service was performed 35 times for 23 patients

Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r

This is a test for COVID-19. It uses high-tech methods to find the virus's genetic material in your body. The amplified probe technique helps detect the virus even in small amounts. This is crucial for early detection and effective treatment.

This service was performed 35 times for 23 patients

Interpretation and report of genetic testing

Interpretation and report of genetic testing involves analyzing your DNA to look for changes that could indicate a risk for certain health conditions. The results are then compiled into a report, which provides insights about your genetic health.

This service was performed 216 times for 203 patients

Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure

Microscopic genetic analysis of tissue is a detailed lab process that examines your cells' genetic material. If more than one stain procedure is needed, it's termed an 'additional multiplex stain procedure'. This helps to highlight different components within your cells, aiding in accurate diagnosis and treatment planning.

This service was performed 785 times for 176 patients

Pap test

A Pap test is a routine exam that checks for changes in cells that could signal a health concern. During this test, a small sample of cells is gently collected from the lower region of the body. The sample is then examined under a microscope to ensure everything looks normal.

This service was performed 22 times for 21 patients

Pap test, automated thin layer preparation; automated system and manual rescreening

A Pap test is a screening tool that helps detect unusual cells. The automated thin layer preparation involves placing your cell sample in a thin layer on a slide. An automated system then scans the slide, and experts manually review any areas flagged by the system. This method enhances the accuracy of the results.

This service was performed 21 times for 20 patients

Tissue culture for tumor disorders of bone marrow and blood cells

Tissue culture for tumor disorders of bone marrow and blood cells is a lab process where your cells are grown in a controlled environment. The aim is to detect and study abnormal cells, such as cancer, in your bone marrow or blood. This helps in planning effective treatment.

This service was performed 202 times for 137 patients

CLIA Information

The Clinical Laboratory Improvement Amendments (CLIA) of 1988 applies to facilities or sites that test human specimens for health assessment or to diagnose, prevent, or treat disease. The CLIA Program sets standards for clinical laboratory testing and issues certificates. The NPI / CLIA crosswalk information for this NPI number is:

CLIA Number
50D0721329
Facility Type
Independent
Certificate Effective Date
August 30, 1996
Certificate Expiration Date
April 04, 2028
Laboratory Director
DR. MICHAEL H. KALNOSKI
Certificate Type
Certificate of Accreditation
Certificate Type Description
This is a CLIA certificate is issued to Diagnostic Cytogenetics on the basis of the laboratory's accreditation by an accreditation organization approved by CMS. This type of certificate is issued to a laboratories tha perform nonwaived (moderate and/or high complexity) testing.

Reviews for DIAGNOSTIC CYTOGENETICS

There are currently no reviews for this provider. Be the first person to share your experience with this provider by filling out our review form. Your insights are appreciated and will help others make informed decisions.

NPI NPI Number Validation

How NPI Validation Works

The NPI validation process uses the ISO-standard Luhn algorithm, a mathematical "handshake", to ensure that a provider's 10-digit ID is authentic and free of common typing errors.

To verify the NPI 1104899376, we treat the final digit (6) as the Check Digit—the target answer we need to reach. The process begins by taking the first nine digits and adding a constant value of 24, which accounts for the "80840" prefix required for all U.S. health identifiers. We then double every other digit starting from the right and sum the individual digits of those results together. For this specific NPI, that total comes to 64. The final step is to find the difference between that total and the next multiple of ten (70 - 64 = 6).

Digit-by-digit view

Use the first nine digits for the calculation. Starting from the right, double every other digit. The last digit is the check digit and is not part of the calculation.

Pos 1
1
Doubled → 2
Pos 2
1
Unchanged
Pos 3
0
Doubled → 0
Pos 4
4
Unchanged
Pos 5
8
Doubled → 16 → 1 + 6
Pos 6
9
Unchanged
Pos 7
9
Doubled → 18 → 1 + 8
Pos 8
3
Unchanged
Pos 9
7
Doubled → 14 → 1 + 4
Check
6
Target digit
Regular digit Doubled digit Check digit

Step 1: Double every other digit from the right

Starting with the rightmost digit of the first nine digits, double every other value. If doubling creates a two-digit number, add those digits together.

1 → 2 0 → 0 8 → 16 → 7 9 → 18 → 9 7 → 14 → 5

Step 2: Add all digits plus the NPI constant

Add the transformed values, the unchanged digits, and the constant 24.

2 + 1 + 0 + 4 + 1 + 6 + 9 + 1 + 8 + 3 + 1 + 4 + 24 = 64

Step 3: Find the amount needed to reach the next multiple of 10

The next multiple of ten after 64 is 70. The difference is the calculated check digit.

70 - 64 = 6
This NPI is valid
The calculated check digit is 6, which matches the last digit of 1104899376.

Frequently Asked Questions

The NPI number assigned to this healthcare provider is 1104899376, enumerated as an "organization" on February 08, 2006.

The provider is located at 2360 W COMMODORE WAY STE 201 SEATTLE, WA 98199 and the phone number is (206) 328-2026.

Clinical Medical Laboratory with taxonomy code 291U00000X.

The provider might be accepting Accepts: PacificSource Health Plans, Premera Blue Cross. Please consult your insurance carrier or call the provider to verify.